MORE►
CPRIT
[Image: ADragan/istockphoto]
CPRIT Awards Grants to 15 Dallas-Fort Worth Researchers in Latest Funding Round
by Dallas Innovates | Staff Report | Dec 5, 2025
The Cancer Prevention & Research Institute of Texas offers funding opportunities for promising cancer research, product development, and prevention programs. The state-funded initiative stands as the second-largest public backer of cancer research in the U.S. after the National Cancer Institute.
by Glenn Hunter |
Sep 24, 2025
At Dallas’ iC3 Summit, leaders from Texas and across the U.S. pointed to AI, new state initiatives like Proposition 14, and potential federal reforms as keys to speeding innovation and keeping America competitive in life sciences.
MORE►
by Lance Murray |
Feb 27, 2024
Included in the 12 Dallas-area funding awards is a $4 million Rising Star grant to bring Stefan Gloeggler, Ph.D., to UT Southwestern Medical Center from the Max Planck Institute of Multidisciplinary Sciences in Göttingen, Germany.
MORE►
by Lance Murray |
Aug 17, 2023
The 29 new grants approved by CPRIT's Oversight Committee include the first CPRIT Scholar award to Southern Methodist University in Dallas and state funding for Dallas' Baylor Research Institute to join a major National Cancer Institute study.
MORE►
UT Southwestern Harold C. Simmons Comprehensive Cancer Center [Photo: UTSW]
CPRIT Awards Over $20M to UT Southwestern and UT Dallas to Fight Cancer
by Dallas Innovates | Staff Report | Feb 17, 2023
The Cancer Prevention and Research Institute of Texas approved over $90 million in new cancer research and prevention grants at its quarterly meeting near the Texas Capitol on Wednesday—and $20.6 million of that money is coming to North Texas to advance everything from breast cancer and lung cancer screening to "deep learning models" to facilitate T-cell receptor therapies.
MORE►
by Kevin Cummings |
Sep 6, 2022
The Cancer Prevention & Research Institute of Texas has provided more than $3.1 billion in funding toward the development of cancer-fighting therapeutics, devices, diagnostics, and tools since 2010. It's now issued a call for startups and early-stage companies to apply for product development research grants for the 2023 fiscal year.
“CPRIT’s mission is to invest in the research prowess of Texas institutions while expediting breakthroughs in cancer cures and prevention,” CEO Wayne Roberts said last May.
MORE►
by David Seeley |
Jun 30, 2022
At the 2022 BIO International Conference in San Diego, representatives from North Texas met "the greatest minds in biotechnology"—and discovered some of them are interested in relocating their companies to DFW.
"We connected with them to explore opportunities and increase investments in the Dallas region,” said a VP with the Dallas Regional Chamber.
"We connected with them to explore opportunities and increase investments in the Dallas region,” said a VP with the Dallas Regional Chamber.
MORE►
by David Seeley |
Oct 25, 2021
The Cancer Prevention and Research Institute of Texas (CPRIT) will convert previous grant awards to an equity investment. OncoNano uses pH as a biomarker to detect metastatic cancer. The technology "lights up" a tumor in imaging during real-time surgery.
MORE►
Dr. David Genecov, left, and John Harkey of Dialectic Therapeutics. [Photos: Courtesy Dialectic Therapeutics]
Dialectic Therapeutics Plans to Further Cancer Drug Research Using $3M Seed Award
by Lance Murray | Feb 26, 2020
Using innovative new technologies and targeted therapies, the Dallas biotech startup aims to help patients with cancer, give them hope, and prolong their lives.
MORE►
by Lance Murray |
Aug 27, 2019
Southlake-based biotech OncoNano received the largest grant in DFW with $15.4 million from the state agency that funds cancer research in Texas.
MORE►
by Lance Murray |
May 31, 2019
You’ll also find out about how a UT Dallas professor is trying to speed up transistors for chipmakers, and about how Caris Life Sciences’ new collaboration is developing a cancer diagnostic test in this roundup of research and development activity in North Texas.
MORE►
by Nicholas Sakelaris |
Oct 13, 2017
From the future of Cancer Prevention & Research Institute of Texas grants to patient records innovation, leaders discussed issues facing the industry.
MORE►
